Keryx Biopharmaceuticals, Inc. · New York, NY United States ·(NASDAQ (GM): KERX)
Company Description
Phone: 212-531-5965
Fax: 212-531-5961
View Keryx Biopharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Drugs are a life-or-death business for Keryx Biopharmaceuticals. The company specializes in developing treatments for life-threatening ailments, such as cancer and kidney disease. Its lead candidate is Zerenex, a compound that may reduce high phosphate levels in patients with end-stage renal disease. The company is also developing KRX-0401 (also known as perifosine) to fight renal cell carcinoma and other cancers. Keryx suffered a major blow in 2008 when its previous lead candidate Sulonex failed in a pivotal clinical trial; the drug had been intended to treat diabetic nephropathy, a diabetes-related kidney disease. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Keryx Biopharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GM): KERX Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $1.3 |
| 2008 Employees | 17 |
Keryx Biopharmaceuticals, Inc. Executives
13 executives listed for Keryx Biopharmaceuticals, Inc.'s New York, NY location.
| Title | Name & Bio | Contact |
| Corporate Programs Director | Wendy Whitfield | Network |
| CEO and Director | Ron Bentsur | Network |
| VP Finance, Treasurer, and Corporate Secretary | James Oliviero | Network |
Competition
Top Keryx Biopharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!